Search Results

The Ceralas Fiber-Coupled 1470nm Diode Laser family (and their delivery accessories used to deliver optical energy) are indicated for use in general surgical applications for incision, excision, ablation, cutting, vaporization, hemostasis, and coagulation of soft tissue contact or non-contact, open or closed endoscopic applications where incision, tissue dissection, excision of external tumors and lesions, complete or partial resection of internal organs, tumors and lesions, tissue vaporization, hemostasis and/or coagulation may be indicated. Added Indication for Use: Laser Assisted Lipolysis

The Ceralas 1470nm contains the same basic components as the cleared Ceralas 980nm family and substantially similar technologies to the cleared Quanta 980 and 1470nm families.

The provided text does not contain information about specific acceptance criteria or a study that evaluated the device's performance against such criteria for the added indication of Laser Assisted Lipolysis. Instead, this document is a 510(k) summary and an FDA clearance letter, which focus on demonstrating substantial equivalence to predicate devices rather than primary clinical performance data.

Therefore, I cannot populate the table or answer the questions as requested, as the necessary information is not present in the given text.

The document indicates that the Ceralas 1470nm Diode Laser family is considered "as safe and effective for this additional Indication for Use as the Ceralas 980nm Family and the Quanta System 980nm & 1470nm laser family" based on having "the same intended uses, indications, technological characteristics, and principles of operation as its predicate devices." This is a statement of substantial equivalence, not a report of a new performance study.

Ask a specific question about this device